REGISTERED
on 20 Feb 2024
Last Applicant/ Owned by
30 Florida Ave., N. W., Unit #6
Washington, D. C.
DC
20001
Serial Number
90863643 filed on 03rd Aug 2021
Registration Number
7311964 registered on 20th Feb 2024
Correspondent Address
Francis G. Gleason Jr.
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
THE SUSTAINABLE HEALTHCARE CO
Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central ne Read More
Classification Information
Class [035]
Advertising, Business & Retail Services
Retail pharmacy services; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
First Use Date in General
18th Nov 2022
First Use Date in Commerce
18th Nov 2022
Class [005]
Pharmaceutical Products
Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs
First Use Date in General
18th Nov 2022
First Use Date in Commerce
18th Nov 2022
Specimens
Mark Details
Serial Number
No 90863643
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 20th Feb 2024 | REGISTERED-SUPPLEMENTAL REGISTER |
| 20th Feb 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 17th Jan 2024 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| 16th Jan 2024 | USE AMENDMENT ACCEPTED |
| 16th Jan 2024 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| 26th Dec 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 26th Dec 2023 | EXAMINERS AMENDMENT E-MAILED |
| 26th Dec 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 26th Dec 2023 | EXAMINER'S AMENDMENT ENTERED |
| 28th Aug 2023 | NON-FINAL ACTION WRITTEN |